BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2749511)

  • 1. Computerized perimetric monitoring and study of scotomatous fluctuations in timolol-treated open-angle glaucoma patients.
    Pecori-Giraldi J
    Surv Ophthalmol; 1989 Apr; 33 Suppl():423-5; discussion 435-6. PubMed ID: 2749511
    [No Abstract]   [Full Text] [Related]  

  • 2. Visual field survival: the response to timolol therapy in open-angle glaucoma.
    Sponsel WE; Dallas NL; Burbridge L
    Br J Ophthalmol; 1983 Apr; 67(4):220-7. PubMed ID: 6830740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The favorable effect of topical betaxolol and timolol on glaucomatous visual fields: a 2-year follow-up study.
    Vainio-Jylhä E; Vuori ML
    Graefes Arch Clin Exp Ophthalmol; 1999 Feb; 237(2):100-4. PubMed ID: 9987624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short term effects of timolol in chronic glaucoma. A double blind study using computerized perimetry.
    Holmin C; Krakau CE
    Acta Ophthalmol (Copenh); 1982 Jun; 60(3):337-46. PubMed ID: 7136544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year follow-up of timolol-treated open-angle glaucoma.
    Goethals M
    Surv Ophthalmol; 1989 Apr; 33 Suppl():463-4; discussion 471-2. PubMed ID: 2749519
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of pindolol and timolol treatment on the visual fields of glaucoma patients.
    Flammer J; Robert Y; Gloor B
    J Ocul Pharmacol; 1986; 2(4):305-11. PubMed ID: 3503114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term effect of domestic timolol on patients with primary open-angle glaucoma].
    Hu C
    Zhonghua Yan Ke Za Zhi; 1984 Jan; 20(1):6-13. PubMed ID: 6434275
    [No Abstract]   [Full Text] [Related]  

  • 9. Longterm visual field follow-up of glaucoma patients treated with beta-blockers.
    Kaiser HJ; Flammer J; Stümpfig D; Hendrickson P
    Surv Ophthalmol; 1994 May; 38 Suppl():S156-9; discussion S160. PubMed ID: 7940137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of carteolol and timolol on IOP an visual fields in glaucoma: a multi-center, double-masked, prospective study.
    Flammer J; Kitazawa Y; Bonomi L; Mills B; Fsadni M; Dorigo MT; Shirato S; Journel B; Chavy B; Chevallier B
    Eur J Ophthalmol; 1992; 2(4):169-74. PubMed ID: 1490088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects on the intraocular pressure and visual field resulting from a switch in the treatment from timolol to betaxolol.
    Miki H; Miki K
    J Ocul Pharmacol Ther; 2004 Dec; 20(6):509-17. PubMed ID: 15684810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of timolol versus pilocarpine on visual field progression in patients with primary open-angle glaucoma.
    Vogel R; Crick RP; Mills KB; Reynolds PM; Sass W; Clineschmidt CM; Tipping R
    Ophthalmology; 1992 Oct; 99(10):1505-11. PubMed ID: 1454315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in visual function after intraocular pressure reduction using antiglaucoma medications.
    Prata TS; Piassi MV; Melo LA
    Eye (Lond); 2009 May; 23(5):1081-5. PubMed ID: 18670465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of betaxolol and timolol on the visual fields of patients with glaucoma.
    Messmer C; Flammer J; Stümpfig D
    Am J Ophthalmol; 1991 Dec; 112(6):678-81. PubMed ID: 1957903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of dorzolamide/timolol and latanoprost/timolol fixed combinations upon intraocular pressure and progression of visual field damage in primary open-angle glaucoma.
    Pajic B; Pajic-Eggspuehler B; Häfliger IO
    Curr Med Res Opin; 2010 Sep; 26(9):2213-9. PubMed ID: 20673200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of ophthalmic beta-adrenoceptor antagonists on intraocular pressure and retinal sensitivity in primary open-angle glaucoma.
    Collignon-Brach J
    Curr Eye Res; 1992 Jan; 11(1):1-3. PubMed ID: 1559386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between visual field severity and response to fixed combination dorzolamide/timolol or timolol alone.
    Olander KW; Galet VA; Jia G; Smugar SS; Stewart WC
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):357-64. PubMed ID: 19441888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic value of citicoline in the treatment of glaucoma (computerized and automated perimetric investigation).
    Pecori Giraldi J; Virno M; Covelli G; Grechi G; De Gregorio F
    Int Ophthalmol; 1989 Jan; 13(1-2):109-12. PubMed ID: 2744938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma.
    Martínez A; Sanchez-Salorio M
    Acta Ophthalmol; 2010 Aug; 88(5):541-52. PubMed ID: 19799592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of patients with primary open-angle glaucoma with a fixed combination of brimonidine 0.2%/timolol 0.5%: multicenter, open-label, observational study in Germany.
    Thelen U; Buchholz P; Kimmich F
    Curr Med Res Opin; 2009 Apr; 25(4):1003-9. PubMed ID: 19275517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.